6J Biotechnology (Hong Kong) Limited
Michelle Zhang
The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
[Incubio's Incubatee] 6J Biotechnology is devoted to developing new generation anti-metastasis drugs based on endosomal trafficking. Our mission is to control or abolish the metastasis of the malignant tumors, thereby converting cancer into a chronic disease and allowing cancer patients to live better and longer. In order to identify more efficient and specific endosomal trafficking modulators, we screened natural compounds library or commercial small molecule compounds library through high-content fluorescence imaging of cells and identified a few endosomal trafficking regulators. We are currently developing these small molecules into next generation anti-metastasis drugs.